Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-09-23 | New | $796,328 | $796,328 | Debt Only | 06b | SEC link |
| 2024-08-12 | New | $0 | $0 | Equity Only | 06b | SEC link |
| 2023-05-31 | New | $260,000 | $260,000 | Other | 06b | SEC link |
| 2022-02-15 | Amended | $853,500 | $50,000 | Other | 06b | SEC link |
| 2022-01-28 | Amended | $803,500 | $708,500 | Other | 06b | SEC link |
| 2020-11-10 | New | $95,000 | $95,000 | Other | 06b | SEC link |
| Name | Role |
|---|---|
| Somer Baburek | Director, Executive |
| Paul Castella | Director |
| Wendy Smith | Director |
| Neal Walsdorf, Jr. | Director |